APA (7th ed.) Citation

Tian, Z., Cen, L., Wei, F., Dong, J., Huang, Y., Han, Y., . . . Jiang, Y. (2025). EGFR mutations in non-small cell lung cancer: Classification, characteristics and resistance to third-generation EGFR-tyrosine kinase inhibitors (Review). Oncology Letters, 30(2), N.PAG. https://doi.org/10.3892/ol.2025.15121

Chicago Style (17th ed.) Citation

Tian, Zhe, Lilan Cen, Feng Wei, Jue Dong, Yulan Huang, Yi Han, Zhibo Wang, Junhua Deng, and Yujie Jiang. "EGFR Mutations in Non-small Cell Lung Cancer: Classification, Characteristics and Resistance to Third-generation EGFR-tyrosine Kinase Inhibitors (Review)." Oncology Letters 30, no. 2 (2025): N.PAG. https://doi.org/10.3892/ol.2025.15121.

MLA (9th ed.) Citation

Tian, Zhe, et al. "EGFR Mutations in Non-small Cell Lung Cancer: Classification, Characteristics and Resistance to Third-generation EGFR-tyrosine Kinase Inhibitors (Review)." Oncology Letters, vol. 30, no. 2, 2025, p. N.PAG, https://doi.org/10.3892/ol.2025.15121.